NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1558546192 MD
Verify on CMS → Himani Singh, MD
Hematology & Oncology Physician in Oceanside, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
484
Medicare Part D claims · 105 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.0K
32 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Himani Singh, MD filed 484 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Oceanside, California, prescribing 68% generic.
- 484
- Part D claims, 2023
- 68%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Himani Singh, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
484 Top 38% higher than 62% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Himani Singh, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Himani Singh, MD?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
484 43% vs specialty avg
Specialty distribution in California
How Hematology & Oncology Physician compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Himani Singh, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 3617 VISTA WAY, Oceanside, CA, 92056, with a listed phone of (760) 758-5770. NPI 1558546192 was issued on 01/02/2008.
Medicare Part D records for calendar year 2023 show 484 prescription claims written by this provider, covering 105 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 32% brand-name and 68% generic by claim count.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1558546192 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 01/02/2008 |
Hospital and facility affiliations
Facilities where Himani Singh, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
North County Oncology Medical Clinic Inc
Oceanside, CA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Himani Singh, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.0K
Largest payer
PFIZER INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Himani Singh, MD. To verify Himani Singh, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Himani Singh, MD - brand share 32.0%
Hematology & Oncology Physician average
32% brand-name claims vs 68% generic, on 484 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
484
Total Claims
$1.8M
Total Drug Cost
105
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 895
- Total Day Supply
- 25,424
- Brand vs Generic
- 32% brand / 68% generic
- Brand Drug Cost
- $1.8M
- Generic Drug Cost
- $60K
- Antibiotic Claims
- 13
Patient Demographics
- Average Patient Age
- 77.0 years
- Avg HCC Risk Score
- 2.38
- Gender Split
- 75% female / 25% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Himani Singh, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
138 claims
- Hydroxyurea 46
Hydroxyurea
46 claims
- Ibrance 26
Ibrance
26 claims
- Procrit 24
Procrit
24 claims
- Xarelto 22
Xarelto
22 claims
- Potassium Chloride 16
Potassium Chloride
16 claims
- Exemestane 14
Exemestane
14 claims
- Mirtazapine 14
Mirtazapine
14 claims
| Drug | Claims |
|---|---|
| Anastrozole | 138 |
| Hydroxyurea | 46 |
| Ibrance Palbociclib | 26 |
| Procrit Epoetin Alfa | 24 |
| Xarelto Rivaroxaban | 22 |
| Potassium Chloride | 16 |
| Exemestane | 14 |
| Mirtazapine | 14 |
| Revlimid Lenalidomide | 13 |
| Cabometyx Cabozantinib S-Malate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Himani Singh, MD fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Himani Singh, MD's 484 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Singh.
Dr. Mark Abate
M.D.
Santa Barbara, CA
Dr. Iman Abdalla
MD
Los Angeles, CA
Dr. Nihal Abdulla
MD
Los Alamitos, CA
Dr. Oyewale Abidoye
M.D.
La Jolla, CA
Dr. Mohamad Adada
M.D., PHD
Roseville, CA
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Himani Singh, MD's specialty? ▼
Himani Singh, MD specializes in Hematology & Oncology Physician and practices in Oceanside, California. Credentials: MD.
How much does Himani Singh, MD prescribe under Medicare Part D? ▼
In 2023, Himani Singh, MD wrote 484 Medicare Part D claims totaling $1.8M in drug costs for 105 beneficiaries.
Where is Himani Singh, MD located? ▼
Himani Singh, MD is located at 3617 VISTA WAY, Oceanside, CA, 92056. Phone: (760) 758-5770.
What is Himani Singh, MD's NPI number? ▼
Himani Singh, MD's National Provider Identifier (NPI) is 1558546192, issued on 01/02/2008.
Does Himani Singh, MD prescribe more brand-name or generic drugs? ▼
Himani Singh, MD's prescribing is 32% brand-name and 68% generic drugs by claim count, with $1.8M in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Himani Singh, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Himani Singh, MD's most frequently prescribed drugs include Anastrozole, Hydroxyurea, Ibrance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Himani Singh, MD accept Medicare? ▼
Himani Singh, MD appears in CMS Medicare data with 484 Part D claims and 105 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Himani Singh, MD's credentials? ▼
Himani Singh, MD's NPI is 1558546192 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.